Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure

@article{HosseiniZare2012PeripheralNR,
  title={Peripheral neuropathy response to erythropoietin in type 2 diabetic patients with mild to moderate renal failure},
  author={Mahshid S Hosseini-Zare and S. Dashti-Khavidaki and M. Mahdavi-Mazdeh and F. Ahmadi and S. Akrami},
  journal={Clinical Neurology and Neurosurgery},
  year={2012},
  volume={114},
  pages={663-667}
}
This study assessed the added effect of 6 months of erythropoietin (EPO) administration in patients suffering from diabetic neuropathy with mild to moderate chronic kidney disease (CKD) managed with gabapentin. Twenty diabetic patients with mild to moderate CKD were included; 12 in gabapentin and 8 in EPO+gabapentin group. The subjects underwent nerve conduction studies (NCS) at the initiation of the investigation and after 6-month treatment. NCS were made in deep and superficial peroneal… Expand
Recombinant Human Erythropoietin Restrains Oxidative Stress in Streptozotocin-induced Diabetic Rats Exposed to Renal Ischemia Reperfusion Injury.
TLDR
It is suggested that rhEPO preconditioning can attenuate diabetic RI/RI through regulating endogenous antioxidant activity and improving renal function in the erythropoietin group. Expand
Electrophysiological measurements of diabetic peripheral neuropathy: A systematic review.
TLDR
The methodological review has found that the best method for quantitative indication of the peripheral neuropathy compared with all other methods is clinical electrophysiological examination. Expand
The importance of association between angiotensin-converting enzyme (ACE) Gene I/D polymorphism and diabetic peripheral neuropathy.
TLDR
ACE gene I/D polymorphism may be useful for taking early measures and avoiding DPN in a Turkish population and may research in DM patients to determine genetic predisposition for DPN. Expand
Influence Of Oxidative Stress On Erythrocyte’s Formation And Function Resulting In Anemia
Anemia is a condition with a reduced amount of total blood cell (RBC) or blood hemoglobin or reduced blood oxygen-carrying capacity. Blood loss, decreased production of red blood cells and increasedExpand
Erythropoietin attenuates oxidative stress and apoptosis in Schwann cells isolated from streptozotocin‐induced diabetic rats
TLDR
Although erythropoietin was demonstrated to have neuroprotective effects in neurodegenerative diseases, the effects of EPO on glucose‐evoked oxidative stress and apoptosis of SCs remain unknown. Expand
Complex regional pain syndrome associated with erythropoietin therapy.
TLDR
El paciente fue trasplantado hace 15 años mediante trasplante de donante cadáver previa administración de corticosteroides, micofenolato mofetil, tacrolimus y basiliximab como terapia de inducción inmunosupresora y posteriormente de mantenimiento suprimiendo únicamente el basilximab. Expand
Neuroprotective Effects of Concomitant Use of Erythropoietin and Progesterone in Traumatic Brain Injury
TLDR
The next generation of scientists will have to think more strategically about how to combine big data and big data analytics in the coming generation of smartphones. Expand

References

SHOWING 1-10 OF 36 REFERENCES
Effect of erythropoietin therapy on polyneuropathy in predialytic patients.
TLDR
Subcutaneous EPO therapy improved motor polyneuropathy in uremic patients, especially non-diabetic individuals, and this non-hematopoietic effect may be related to some direct action through EPO receptors on peripheral neurons. Expand
Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure.
TLDR
Autonomic neuropathy is associated with a blunted EPO response to anemia in type 2 diabetic patients without advanced renal failure and multiple linear regression analysis revealed that cardiovascular autonomic neuropathy score was independently related to Hb. Expand
Anemia with erythropoietin deficiency occurs early in diabetic nephropathy.
TLDR
Anemia associated with EPO deficiency can occur early in DN before the onset of advanced renal failure, but does not normally occur in nondiabetic renal disease of similar severity. Expand
Accelerated neuropathy of renal failure.
TLDR
This partly reversible acute uremic neuropathy, which is probably caused by the metabolic disturbances of end-stage renal failure, simulates Guillain-Barré syndrome or chronic inflammatory demyelinating polyneuropathy and may be complicated by diabetic neuropathy. Expand
Inappropriately low erythropoietin response for the degree of anemia in patients with noninsulin-dependent diabetes mellitus
TLDR
Inappropriately low serum Epo level is a uniform feature in patients with type II diabetes mellitus and may represent a constitutive blunted response to anemia or an altered metabolic rate of Epo, probably as a result of abnormal glycosylation of the cytokine. Expand
Peripheral neuropathies associated with chronic renal failure.
  • C. Bolton
  • Medicine
  • The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  • 1980
TLDR
While chronic hemodialysis stabilizes uremic neuropathy, manipulation of he modialysis schedules may not alter its course, according to current assessment. Expand
Utility of dorsal sural nerve in early determination of diabetic polyneuropathy
TLDR
The value of dorsal sural nerve to diagnose early polyneuropathy in diabetic patients with normal routine nerve conduction studies is reported, and no statistically significant difference was found for conduction velocities and distal latencies of sural nerves between the diabetic patients and the controls. Expand
Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
TLDR
Gabapentin monotherapy appears to be efficacious for the treatment of pain and sleep interference associated with diabetic peripheral neuropathy and exhibits positive effects on mood and quality of life. Expand
Nerve biopsy and conduction studies in diabetic neuropathy.
Morphological findings in sural nerves were related to nerve conduction in 12 patients with diabetic neuropathy, five with mainly sensory involvement, four with severe, symmetrical sensory-motorExpand
The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus.
TLDR
There is a correlation between HbA1c levels and nerve conduction velocity in posterior tibial and peroneal nerves, however, upper extremity nerveConduction dysfunction was not correlated with Hb a1c value and neither the duration of disease nor the age of the subject correlated with the nerve dysfunction. Expand
...
1
2
3
4
...